39
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Aminoglycoside-associated Severe Renal Failure in Patients with Multiple Myeloma Treated with Thalidomide

, , , &
Pages 1711-1712 | Received 03 Oct 2003, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Efstathios Kastritis, Evangelos Terpos & Meletios A Dimopoulos. (2013) Current treatments for renal failure due to multiple myeloma. Expert Opinion on Pharmacotherapy 14:11, pages 1477-1495.
Read now
Eric D. Batts, Vaishali Sanchorawala, Yael Hegerfeldt & Hillard M. Lazarus. (2008) Azotemia associated with use of lenalidomide in plasma cell dyscrasias. Leukemia & Lymphoma 49:6, pages 1108-1115.
Read now

Articles from other publishers (15)

Rania Kheder El-Fekih & Hassan Izzedine. (2016) Néphrotoxicité du lénalidomide. Bulletin du Cancer 103:5, pages 499-506.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 207 209 .
Norbert Grzasko, Marta Morawska & Marek Hus. (2015) Optimizing the Treatment of Patients With Multiple Myeloma and Renal Impairment. Clinical Lymphoma Myeloma and Leukemia 15:4, pages 187-198.
Crossref
Esftathios Kastritis, Meletios A. Dimopoulos & Joan Bladé. (2012) Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective. Advances in Chronic Kidney Disease 19:5, pages 312-323.
Crossref
Asher A. Chanan-Khan, Jesús F. San Miguel, Sundar Jagannath, Heinz Ludwig & Meletios A. Dimopoulos. (2012) Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment. Clinical Cancer Research 18:8, pages 2145-2163.
Crossref
. (2012) References. Kidney International Supplements 2:1, pages 124-138.
Crossref
. (2012) Section 3: Prevention and Treatment of AKI. Kidney International Supplements 2:1, pages 37-68.
Crossref
M A Dimopoulos, E Kastritis, L Rosinol, J Bladé & H Ludwig. (2008) Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 22:8, pages 1485-1493.
Crossref
Stuart M. Lichtman, Hans Wildiers, Vincent Launay-Vacher, Christopher Steer, Etienne Chatelut & Matti Aapro. (2007) International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. European Journal of Cancer 43:1, pages 14-34.
Crossref
Alexander Imhof & Reto Laffer. 2007. 253 279 .
M. Teresa Cibeira, Laura Rosiñol, Laia Ramiro, Jordi Esteve, Montserrat Torrebadell & Joan Bladé. (2006) Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration. European Journal of Haematology 77:6, pages 486-492.
Crossref
Joan Bladé & Laura Rosiñol. (2005) Renal, hematologic and infectious complications in multiple myeloma. Best Practice & Research Clinical Haematology 18:4, pages 635-652.
Crossref
Svetlana Karie, Vincent Launay-Vacher, Hassane Izzedine & Gilbert Deray. (2005) Néphrotoxicité des médicaments : veille bibliographique janvier 2003–décembre 2004. Néphrologie & Thérapeutique 1:5, pages 285-295.
Crossref
Tarek M El-Achkar, Asif A Sharfuddin & Jesus Dominguez. (2005) Approach to Acute Renal Failure With Multiple Myeloma: Role of Plasmapheresis. Therapeutic Apheresis and Dialysis 9:5, pages 417-422.
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.